Profit finally in sight for gene therapy specialist Oxford Bio – Times of India
|
Profit finally in sight for gene therapy specialist Oxford Bio
Times of India Makes key component of pioneering Novartis cancer therapy. * Analysts expect full-year net profit from 2019. By Ben Hirschler. LONDON, Aug 23 (Reuters) – After 20 years of losses, gene therapy specialist Oxford BioMedica is at last close to achieving … |
